Florin Court Capital LLP Has $5.08 Million Position in iShares Biotechnology ETF $IBB

Florin Court Capital LLP lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 60.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 30,100 shares of the financial services provider’s stock after selling 46,900 shares during the quarter. iShares Biotechnology ETF makes up 7.1% of Florin Court Capital LLP’s portfolio, making the stock its 3rd biggest position. Florin Court Capital LLP owned 0.06% of iShares Biotechnology ETF worth $5,080,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. BNP Paribas Financial Markets raised its stake in shares of iShares Biotechnology ETF by 313.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock worth $276,526,000 after acquiring an additional 1,451,820 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of iShares Biotechnology ETF by 27.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after acquiring an additional 226,852 shares in the last quarter. Truist Financial Corp raised its stake in shares of iShares Biotechnology ETF by 2,239.6% during the 4th quarter. Truist Financial Corp now owns 642,023 shares of the financial services provider’s stock worth $108,354,000 after acquiring an additional 614,582 shares in the last quarter. WestEnd Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $106,276,000. Finally, Jefferies Financial Group Inc. bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $65,083,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.6%

NASDAQ IBB opened at $166.83 on Friday. The company has a 50 day moving average price of $169.24 and a 200 day moving average price of $169.57. iShares Biotechnology ETF has a 52 week low of $118.51 and a 52 week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.